15 October 2025 | News
Image Courtesy: Public Domain
Restore Robotics announced that more than 300 hospitals and surgery centers across the United States have joined its growing recycling and remanufacturing program for da Vinci Xi® robotic surgical instruments. The company continues to receive overwhelmingly positive feedback from surgical teams and hospital administrators who are realizing significant cost savings while supporting sustainability in healthcare.
Restore Robotics, through its Master Distributor, Encore Medical Device Repair (Encore), provides hospitals with FDA-cleared remanufactured robotic instruments that are substantially equivalent to new instruments. The program enables hospitals to recycle expired or used robotic instruments and purchase remanufactured instruments—reducing both procurement costs and environmental waste.
"We're incredibly proud that over 300 hospitals have committed to working with Restore Robotics," said Clif Parker, CEO of Restore Robotics. "The feedback has been extremely positive—hospitals are seeing that remanufactured instruments perform to the same standard as new ones, at a fraction of the cost. It's a win for both budgets and sustainability."
"Hospitals appreciate the transparency, reliability, and quality of the Restore remanufacturing program," added Tom Milano, President and COO of Encore. "This milestone shows that the healthcare industry is ready to embrace responsible reuse—treating robotic instruments as valuable assets, not disposable commodities."
Restore Robotics made history earlier this year by achieving FDA 510(k) clearance to remanufacture the da Vinci® Xi 8 mm Monopolar Curved Scissors. The company continues to expand its pipeline of remanufactured instruments under review with the FDA, with additional clearances expected through 2026.
